A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Condition: Crohn's Disease Interventions: Drug: Upadacitinib; Drug: Placebo for Upadacitinib Sponsor: AbbVie Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials